Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
---|---|---|---|---|---|---|---|---|---|
6,91% | 0 | 55,85% | 2,13% | 2050-08-06 | 500 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC | |
6,29% | 0 | 67,41% | 3,00% | 2051-05-28 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC | |
5,71% | 0 | 86,65% | 4,38% | 2048-08-17 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC | |
5,67% | 0 | 87,63% | 4,38% | 2045-11-16 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC | |
5,66% | 1,33 M | 85,36% | 4,00% | 2042-09-18 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC | |
AAZN5193314AstraZeneca Finance LLC 2.25% 28-MAY-2031 | 4,98% | 2,61 M | 87,01% | 2,25% | 2031-05-28 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
4,96% | 1,25 M | 111,54% | 6,45% | 2037-09-15 | 2,75 B USD | 1 000,00 USD | 1 000,00 USD | AstraZeneca PLC | |
4,94% | 0 | 84,76% | 1,38% | 2030-08-06 | 1,3 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC | |
UUS4636NAN3ASTRAZEN.FI. 24/34 | 4,92% | 0 | 100,51% | 5,00% | 2034-02-26 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
AAZN5549116AstraZeneca Finance LLC 4.875% 03-MAR-2033 | 4,84% | 195 K | 100,21% | 4,88% | 2033-03-03 | 500 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
UUS4636NAM5ASTRAZEN.FI. 24/31 | 4,56% | 0 | 101,59% | 4,90% | 2031-02-26 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
AAZN5193317AstraZeneca Finance LLC 1.75% 28-MAY-2028 | 4,54% | 11,62 M | 92,14% | 1,75% | 2028-05-28 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
4,52% | 0 | 106,30% | 5,75% | 2031-11-13 | 350 M GBP | 1 000,00 GBP | 50 000,00 GBP | AstraZeneca PLC | |
UUS4636NAK9ASTRAZEN.FI. 24/27 | 4,50% | 0 | 100,54% | 4,80% | 2027-02-26 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
UUS4636NAL7ASTRAZEN.FI. 24/29 | 4,47% | 0 | 101,27% | 4,85% | 2029-02-26 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
AAZN5549115AstraZeneca Finance LLC 4.9% 03-MAR-2030 | 4,47% | 890 K | 101,74% | 4,90% | 2030-03-03 | 650 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
4,44% | 0 | 99,28% | 3,38% | 2025-11-16 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC | |
4,39% | 0 | 98,72% | 4,00% | 2029-01-17 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC | |
AAZN5549114AstraZeneca Finance LLC 4.875% 03-MAR-2028 | 4,35% | 5,51 M | 101,40% | 4,88% | 2028-03-03 | 1,1 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
4,31% | 0 | 96,25% | 0,70% | 2026-04-08 | 1,2 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC | |
UUS4636NAA1ASTRAZEN.FI. 21/26 | 4,30% | 0 | 96,39% | 1,20% | 2026-05-28 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
4,24% | 0 | 97,70% | 3,13% | 2027-06-12 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC | |
XXS287290977ASTRAZEN.FI. 24/33 MTN | 3,43% | 0 | 99,01% | 3,28% | 2033-08-05 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca Finance LLC |
3,28% | 0 | 102,66% | 3,75% | 2032-03-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca PLC | |
XXS287290969ASTRAZEN.FI. 24/30 MTN | 3,13% | 0 | 99,97% | 3,12% | 2030-08-05 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca Finance LLC |
3,05% | 0 | 89,95% | 0,38% | 2029-06-03 | 800 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca PLC | |
2,73% | 0 | 101,68% | 3,63% | 2027-03-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca PLC | |
2,65% | 0 | 95,88% | 1,25% | 2028-05-12 | 800 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca PLC |